-
公开(公告)号:US09976145B2
公开(公告)日:2018-05-22
申请号:US13978804
申请日:2012-01-10
申请人: Florian Jarosch , Sven Klussmann , Simone Sell , Werner Purschke , Christian Maasch , Axel Vater , Kai Hohlig
发明人: Florian Jarosch , Sven Klussmann , Simone Sell , Werner Purschke , Christian Maasch , Axel Vater , Kai Hohlig
IPC分类号: C12N15/115 , C12N15/11 , G01N33/53 , C12N15/10
CPC分类号: C12N15/115 , C12N15/102 , C12N15/111 , C12N2310/16 , C12N2310/32 , C12N2320/13 , C12N2330/31 , G01N33/5308 , G01N2400/10 , G01N2500/04
摘要: The present invention is related to a method for generating a nucleic acid molecule capable of binding to a target molecule comprising the following steps: a) providing a reference nucleic acid molecule, wherein the reference nucleic acid molecule is capable of binding to the target molecule and wherein the reference nucleic acid molecule comprises a sequence of nucleotides, wherein the sequence of nucleotides comprises n nucleotides; b) preparing a first level derivative of the reference nucleic acid molecule, wherein the first level derivative of the reference nucleic acid molecule differs from the reference nucleic acid molecule at one nucleotide position, wherein the first level derivative is prepared by replacing the ribonucleotide at the one nucleotide position by a 2′-deoxyribonucleotide in case the reference nucleic acid has a ribonucleotide at the nucleotide position and wherein the first level derivative is prepared by replacing the 2′-deoxyribonucleotide at the one nucleotide position by a ribonucleotide in case the reference nucleic acid has a 2′-deoxyribonucleotide at the nucleotide position and wherein the nucleotide position at which the replacement is made is the modified nucleotide position; and c) repeating step b) for each nucleotide position of the reference nucleic acid molecule, thus preparing a group of first level derivatives of the reference nucleic acid molecule, wherein the group of first level derivatives of the reference nucleic acid molecule consists of n first level derivatives, wherein each of the first level derivatives of the reference nucleic acid molecule differs from the reference nucleic acid molecule by a single nucleotide replacement and wherein each of the first level derivatives of the reference nucleic acid molecule has a single modified nucleotide position which is different from the single modified nucleotide of all of the single modified nucleotide positions of the other first level derivatives of the group of first level derivatives of the reference nucleic acid molecule.
-
公开(公告)号:US20140350088A1
公开(公告)日:2014-11-27
申请号:US13978804
申请日:2012-01-10
申请人: Florian Jarosch , Sven Klussmann , Simone Sell , Werner Purschke , Christian Maasch , Axel Vater , Kai Hohlig
发明人: Florian Jarosch , Sven Klussmann , Simone Sell , Werner Purschke , Christian Maasch , Axel Vater , Kai Hohlig
IPC分类号: C12N15/115 , G01N33/53 , C12N15/10
CPC分类号: C12N15/115 , C12N15/102 , C12N15/111 , C12N2310/16 , C12N2310/32 , C12N2320/13 , C12N2330/31 , G01N33/5308 , G01N2400/10 , G01N2500/04
摘要: The present invention is related to a method for generating a nucleic acid molecule capable of binding to a target molecule comprising the following steps: a) providing a reference nucleic acid molecule, wherein the reference nucleic acid molecule is capable of binding to the target molecule and wherein the reference nucleic acid molecule comprises a sequence of nucleotides, wherein the sequence of nucleotides comprises n nucleotides; b) preparing a first level derivative of the reference nucleic acid molecule, wherein the first level derivative of the reference nucleic acid molecule differs from the reference nucleic acid molecule at one nucleotide position, wherein the first level derivative is prepared by replacing the ribonucleotide at the one nucleotide position by a 2′-deoxyribonucleotide in case the reference nucleic acid has a ribonucleotide at the nucleotide position and wherein the first level derivative is prepared by replacing the 2′-deoxyribonucleotide at the one nucleotide position by a ribonucleotide in case the reference nucleic acid has a 2′-deoxyribonucleotide at the nucleotide position and wherein the nucleotide position at which the replacement is made is the modified nucleotide position; and c) repeating step b) for each nucleotide position of the reference nucleic acid molecule, thus preparing a group of first level derivatives of the reference nucleic acid molecule, wherein the group of first level derivatives of the reference nucleic acid molecule consists of n first level derivatives, wherein each of the first level derivatives of the reference nucleic acid molecule differs from the reference nucleic acid molecule by a single nucleotide replacement and wherein each of the first level derivatives of the reference nucleic acid molecule has a single modified nucleotide position which is different from the single modified nucleotide of all of the single modified nucleotide positions of the other first level derivatives of the group of first level derivatives of the reference nucleic acid molecule.
-
公开(公告)号:US20110027794A1
公开(公告)日:2011-02-03
申请号:US12905910
申请日:2010-10-15
申请人: Sven Klussmann , Florian Jarosch , Axel Vater
发明人: Sven Klussmann , Florian Jarosch , Axel Vater
CPC分类号: C12N15/102 , C12N15/1096 , C12P19/34
摘要: The invention relates to a method for synthesizing a nucleic acid containing modified nucleotides. The method encompasses the following steps: a matrix strand is provided; —a primer which at least partially hybridizes on the matrix strand is provided; —nucleoside triphosphates, at least some of which are modified nucleoside triphosphates, are provided; —a polymerase activity is supplied; and—the matrix strand, the primer, and the nucleoside triphosphates are incubated so as to synthesize a nucleic acid that is substantially complementary to the matrix strand. The polymerase activity can be a reverse transcriptase activity.
摘要翻译: 本发明涉及一种合成含有修饰核苷酸的核酸的方法。 该方法包括以下步骤:提供矩阵线; 提供了在基质链上至少部分杂交的引物; 核苷三磷酸盐,其中至少一些是修饰的核苷三磷酸酯; - 提供聚合酶活性; 并且将基质链,引物和核苷三磷酸盐孵育以合成基本上与基质链互补的核酸。 聚合酶活性可以是逆转录酶活性。
-
公开(公告)号:US07879991B2
公开(公告)日:2011-02-01
申请号:US10513490
申请日:2003-05-06
申请人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfäller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
发明人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfäller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
IPC分类号: C07H21/04
CPC分类号: C12N15/115
摘要: The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.
摘要翻译: 本发明涉及用于CGRP和胰岛淀粉样多肽的拮抗剂,其中所述拮抗剂是核酸,并且所述核酸与CGRP或胰岛淀粉样多肽结合。 所述核酸优选包含L-核苷酸。
-
公开(公告)号:US20080070238A1
公开(公告)日:2008-03-20
申请号:US10572291
申请日:2004-09-14
申请人: Sven Klussmann , Florian Jarosch , Axel Vater
发明人: Sven Klussmann , Florian Jarosch , Axel Vater
CPC分类号: C12N15/102 , C12N15/1096 , C12P19/34
摘要: The invention relates to a method for synthesizing a nucleic acid comprising modified nucleotides. Said method encompasses the following steps: a matrix strand is provided; —a primer which at least partially hybridizes on the matrix strand is provided; —nucleoside triphosphates, at least some of which are modified nucleoside triphosphates, are provided; —a polymerase activity is supplied; and —the matrix strand, the primer, and the nucleoside triphosphates are incubated so as to synthesize a nucleic acid that is substantially complementary to the matrix strand. The inventive method is characterized in that the polymerase activity represents a reverse transcriptase activity.
摘要翻译: 本发明涉及一种合成含有修饰核苷酸的核酸的方法。 所述方法包括以下步骤:提供矩阵线; 提供了在基质链上至少部分杂交的引物; 核苷三磷酸盐,其中至少一些是修饰的核苷三磷酸酯; - 提供聚合酶活性; 并且 - 将基质链,引物和核苷三磷酸盐孵育以合成基本上与基质链互补的核酸。 本发明的方法的特征在于聚合酶活性代表逆转录酶活性。
-
公开(公告)号:US20060183700A1
公开(公告)日:2006-08-17
申请号:US10513490
申请日:2003-05-06
申请人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfaller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
发明人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfaller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
CPC分类号: C12N15/115
摘要: The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.
摘要翻译: 本发明涉及CGRP和胰岛淀粉样多肽的拮抗剂,其中拮抗剂是核酸,所述核酸与CGRP或胰岛淀粉样多肽结合。 所述核酸优选包含L-核苷酸。
-
公开(公告)号:US08497250B2
公开(公告)日:2013-07-30
申请号:US11913526
申请日:2006-05-04
申请人: Axel Vater , Christian Maasch , Sven Klussmann , Werner Purschke , Dirk Eulberg , Florian Jarosch , Klaus Buchner
发明人: Axel Vater , Christian Maasch , Sven Klussmann , Werner Purschke , Dirk Eulberg , Florian Jarosch , Klaus Buchner
IPC分类号: C12N15/115
CPC分类号: C12N15/115 , C12N2310/16 , G01N2500/04
摘要: The present invention relates to the use of a L-nucleic acid as intracellularly active agent.
摘要翻译: 本发明涉及L-核酸作为细胞内活性剂的用途。
-
公开(公告)号:US20090192100A1
公开(公告)日:2009-07-30
申请号:US11913526
申请日:2006-05-04
申请人: Axel Vater , Christian Maasch , Sven Klussmann , Werner Purschke , Dirk Eulberg , Florian Jarosch , Klaus Buchner
发明人: Axel Vater , Christian Maasch , Sven Klussmann , Werner Purschke , Dirk Eulberg , Florian Jarosch , Klaus Buchner
IPC分类号: A61K31/7088 , C07H21/00 , C12N5/06 , C12N9/00 , G01N33/566 , C07K14/47
CPC分类号: C12N15/115 , C12N2310/16 , G01N2500/04
摘要: The present invention relates to the use of a L-nucleic acid as intracellularly active agent.
摘要翻译: 本发明涉及L-核酸作为细胞内活性剂的用途。
-
公开(公告)号:US08507456B2
公开(公告)日:2013-08-13
申请号:US12679307
申请日:2008-09-24
申请人: Werner Purschke , Florian Jarosch , Dirk Eulberg , Sven Klussmann , Klaus Buchner , Christian Maasch
发明人: Werner Purschke , Florian Jarosch , Dirk Eulberg , Sven Klussmann , Klaus Buchner , Christian Maasch
CPC分类号: C12N15/115 , C12N2310/16 , C12N2310/3183 , C12N2310/323 , Y10T436/143333
摘要: The present invention is related to a nucleic acid, preferably binding to C5a, selected from the group comprising type A nucleic acids, type B nucleic acids, type C nucleic acids, type D nucleic acids and nucleic acids having a nucleic acid sequence according to any of SEQ.ID.No. 73 to 79.
摘要翻译: 本发明涉及优选结合C5a的核酸,其选自包含A型核酸,B型核酸,C型核酸,D型核酸和具有根据任何的核酸序列的核酸 SEQ.ID.No. 73到79。
-
公开(公告)号:US20100284961A1
公开(公告)日:2010-11-11
申请号:US12279183
申请日:2007-02-14
申请人: Werner Purschke , Florian Jarosch , Dirk Eulberg , Sven Klussmann , Klaus Buchner , Christian Maasch
发明人: Werner Purschke , Florian Jarosch , Dirk Eulberg , Sven Klussmann , Klaus Buchner , Christian Maasch
IPC分类号: A61K38/19 , C07H21/02 , C07H21/00 , A61K31/7088 , A61K31/7105 , C40B30/00 , G01N33/53 , C40B40/00 , A61P37/02
CPC分类号: C12N15/1136 , C12N15/115 , C12N2310/16 , C12N2310/351 , C12Q1/6813 , G01N33/566
摘要: The present invention is related to a nucleic acid, preferably binding to MCP-1, selected from the group comprising type 1A nucleic acids, type 1B nucleic acids, type 2 nucleic acids, type 3 nucleic acids, type 4 nucleic acids and nucleic acids having a nucleic acid sequence according to any of SEQ. ID. No. 87 to 115.
摘要翻译: 本发明涉及优选结合MCP-1的核酸,其选自1A型核酸,1B型核酸,2型核酸,3型核酸,4型核酸和具有 根据SEQ ID NO:6中任一项所述的核酸序列。 ID。 第87至115号。
-
-
-
-
-
-
-
-
-